Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice.
Connor Thelen, Jonathon Sens, Joseph Mauch, Radhika Pandit, Pothitos M Pitychoutis
Behavioural Brain Research October 1, 2016 DOI: 10.1016/j.bbr.2016.06.041 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical experimental study Peer reviewed |
|---|---|
| Population | Male and female C57BL/6J mice |
| Intervention | Ketamine |
| Dose | 10 mg/kg |
| Duration | 21 days |
| Measures | open field test, forced swim test (FST) |
| Topics | Depression Ketamine Serotonin Esketamine |
| Keywords | 5-hiaa 5-hydroxy-indoleacetic acid Adrs Anova Antidepressant Drn Eaa Fst Gender Hnk N-methyl-d-aspartate Nmda Oft Pfc Snare Syx Stress Adverse drug reactions Analysis of variance Dorsal raphe nucleus Forced swim test Hippocampus Hydroxynorketamine Open field test Prefrontal cortex Serotonin 5-hydroxytryptamine Syntaxin-i Vehicle |
| Key findings | Repeated ketamine treatment (10 mg/kg for 21 days) induced antidepressant-like effects in male mice but anxiety-like and depressive-like effects in female mice, with sustained sex-differentiated neurochemical and molecular changes in the hippocampus. The authors argue these opposite behavioral effects have implications for the sex-oriented use of ketamine in experimental and clinical settings. |
Abstract
One of the most striking discoveries in the treatment of major depression was the finding that infusion of a single sub-anesthetic dose of ketamine induces rapid and sustained antidepressant effects in treatment-resistant depressed patients. However, ketamine's antidepressant-like actions are transient and can only be sustained by repeated drug treatment. Despite the fact that women experience major depression at roughly twice the rate of men, research regarding the neurobiological antidepressant-relevant effects of ketamine has focused almost exclusively on the male sex. Importantly, knowledge regarding the sex-differentiated effects, the frequency and the dose on which repeated ketamine administration stops being beneficial, is limited. In the current study, we investigated the behavioral, neurochemical and synaptic molecular effects of repeated ketamine treatment (10mg/kg; 21days) in male and female C57BL/6J mice. We report that ketamine induced beneficial antidepressant-like effects in male mice, but induced both anxiety-like (i.e., decreased time spent in the center of the open field arena) and depressive-like effects (i.e., enhanced immobility duration in the forced swim test; FST) in their female counterparts. Moreover, repeated ketamine treatment induced sustained sex-differentiated neurochemical and molecular effects, as it enhanced hippocampal synapsin protein levels and serotonin turnover in males, but attenuated glutamate and aspartate levels in female mice. Taken together, our findings indicate that repeated ketamine treatment induces opposite behavioral effects in male and female mice, and thus, present data have far-reaching implications for the sex-oriented use of ketamine in both experimental and clinical research settings.
Comparable studies
Other preclinical and animal studies on ketamine for depression, most cited first.
Citations in the library
Cited by 27
- On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods Neurobiology of Stress September 21, 2018
- Rodent ketamine depression-related research: Finding patterns in a literature of variability Behavioural Brain Research August 13, 2019
- Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One? Frontiers in Psychiatry May 11, 2021
- Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review Frontiers in Psychiatry June 26, 2023
- Fast-acting antidepressant-like effects of ketamine in aged male rats. Pharmacological Reports October 1, 2024
and 22 more in the library
Cites 10
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Science August 19, 2010
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites Nature April 24, 2016
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression American Journal of Psychiatry April 8, 2016
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics Annual Review of Medicine October 23, 2014
- The use of ketamine as an antidepressant: a systematic review and meta‐analysis Human Psychopharmacology: Clinical and Experimental April 7, 2015
and 5 more in the library